4d Pharma Plc - ADR
LBPS
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-8,169,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.4 |
| Beta | 3.27 |
| Outstanding Shares | 8,186,730 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.56 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | 0.55 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | -1.57 |
| Debt to Equity | 0.39 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About 4d Pharma Plc
2,020 employees
CEO: Duncan Peyton